XOMA Royalty (XOMA) Deferred Taxes (2025 - 2026)

XOMA Royalty (XOMA) reported Deferred Taxes of $1000.0 for Q1 2026, down 98.15% sequentially from $54000.0 in Q4 2025.

XOMA Royalty (XOMA) Deferred Taxes (2025 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 2 years of Deferred Taxes data on file, last reported at $1000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -188,883.60
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -65.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 96.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 XOMA Royalty 478.42 Mn 412.34 Mn - 1,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1,000.00
Dec 31, 2025 54,000.00